China Association for the promotion of drugs and follow-up free drug use project of Kemena of Beida pharmaceutical won the third public welfare practice award in 2013

Source: China pharmaceutical promotion association and Beida pharmaceutical industry 2014-02-12 January 16, 2014, the 3rd China public welfare Festival, which attracted much attention, was successfully concluded in Beijing Kemena's follow-up free drug use project of China Pharmaceutical Industry Research and Development Promotion Association (hereinafter referred to as China pharmaceutical promotion association) and Beida Pharmaceutical Co., Ltd (hereinafter referred to as Beida pharmaceutical) won the 2013 public welfare practice award Kemena is a class 1.1 new drug independently developed by Beida pharmaceutical, which is used to treat non-small cell lung cancer At present, lung cancer has become the first cancer cause of death in China, and its incidence rate and mortality rate has increased rapidly in recent ten years According to the latest World Cancer Report 2014 released by the World Health Organization, the number of new cancer cases and deaths in the world increased dramatically in 2012, with China ranking first In terms of global situation, the most common cancer diagnosed in 2012 was lung cancer (1.8 million cases, accounting for 13.0% of the total); the most common cause of cancer death was lung cancer (1.6 million, accounting for 19.4% of the total) Kemena went public on August 12, 2011 Since then, Beida pharmaceutical has carried out the re evaluation of Kemena after listing In order to give back to the society, the company decided that all patients participating in the post market re evaluation study of Kemena would receive free follow-up Kemena treatment drugs provided by the company until the disease progresses if they are judged to be remission or stable after purchasing and using Kemena for 6 months In order to increase the justice and fairness of the free drug use project, the China Council for the promotion of drugs, as an independent third party with credibility, jointly carried out this work with Beida pharmaceutical Since the start of the free drug use project at the end of 2011, about 7300 people have been enrolled in the group so far In 2013, the number of people in the group increased sharply, about 5000, accounting for about 30% of the total number of drug users Up to now, the longest time to receive Kemena's drug donation is 26 months As of December 30, 2013, there are 1256 patients who have received more than 12 times of drug, and 20 patients who have received more than 24 times of drug 6% of the patients applied in the same period This activity benefits thousands of patients, and makes many patients who have entered the countdown to life stand up again Some of them have returned to work and made greater contributions to social development China public welfare festival was established in 2011 It is the first festival named "public welfare" initiated by the mass media It aims to carry forward the modern public welfare spirit, interpret the complete and correct public welfare concept, and guide the healthy public welfare culture At present, the public welfare Festival has become one of the most influential annual events in the field of public charity in China The third China public welfare Festival is jointly sponsored by Shaanxi satellite TV, China net finance, global network, baidu public welfare, China net, Beijing China net, Sohu focus public welfare fund, Sichuan satellite TV, China times, truth seeking well-off magazine, Oriental entrepreneur, manager, American news agency, international business newspaper, new Finance and economics, BNET business school, China news finance, newlevin media and other multimedia and institutions The theme of this public welfare Festival is: starting from public welfare, walking with beauty As the first enterprise providing follow-up free medication for lung cancer patients in China, Beida pharmaceutical industry is becoming an example of the industry and is concerned by the society Better medicine, better life and Beida pharmaceutical are implementing the concept of "to be an affordable anti-cancer drug for Chinese people" advocated by Dr Ding liming, chairman of the board of directors Kemena free medicine project won the 2013 public welfare practice award of China public welfare Festival, which is a full affirmation of the dedication of Beida pharmaceutical industry to the community The full support of China Council for the promotion of drugs for the project fully reflects the concept of being a responsible industry organization and actively disseminating positive energy